Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
YPF Sociedad Anonima ADR | YPF | Jun 27, 2024 | 20.72 | +2.17 |
YS Biopharma | YS | Jun 27, 2024 | 1.02 | 0.00 |
Yum China | YUMC | Jun 27, 2024 | 31.32 | -0.57 |
Yum! Brands | YUM | Jun 27, 2024 | 132.61 | +0.49 |
Yunhong Green CTI | YHGJ | Jun 27, 2024 | 1.21 | +4.31 |
Yunji ADR | YJ | Jun 27, 2024 | 0.69 | -4.62 |
YY Group Holding | YYGH | Jun 27, 2024 | 0.92 | 0.00 |
Zai Lab ADR | ZLAB | Jun 27, 2024 | 17.52 | -2.50 |
Zalatoris II Acquisition | ZLS | Jun 27, 2024 | 10.95 | -0.01 |
Zapata Computing | ZPTA | Jun 27, 2024 | 0.59 | 0.00 |
Zapp Electric Vehicles Group | ZAPP | Jun 27, 2024 | 2.23 | +11.50 |
ZC SP ETN REDEEM 19/07/2050 USD 25 - Ser B | AMND | Jun 27, 2024 | 44.93 | -0.04 |
ZC SP ETN REDEEM 20/10/2050 USD 25 - Series B | AMTR | Jun 27, 2024 | 60.84 | +0.05 |
Zebra Technologies A | ZBRA | Jun 27, 2024 | 306.99 | -0.04 |
Zedge B | ZDGE | Jun 27, 2024 | 3.02 | +5.96 |
ZEEKR Intelligent Technology Holding | ZK | Jun 27, 2024 | 20.18 | 0.00 |
Zentalis Pharmaceuticals | ZNTL | Jun 27, 2024 | 4.20 | +0.96 |
Zentek | ZTEK | Jun 27, 2024 | 1.02 | -5.12 |
Zenvia A | ZENV | Jun 27, 2024 | 2.67 | +1.14 |
Zeo Energy A | ZEO | Jun 27, 2024 | 2.18 | -31.66 |
Zepp Health ADR | ZEPP | Jun 27, 2024 | 0.60 | -0.20 |
Zeta Global A | ZETA | Jun 27, 2024 | 17.32 | +5.48 |
Zevia A | ZVIA | Jun 27, 2024 | 0.81 | +9.01 |
Zevra Therapeutics | ZVRA | Jun 27, 2024 | 4.81 | +3.44 |
Zhibao Technology | ZBAO | Jun 27, 2024 | 4.02 | 0.00 |
Zhihu A ADR | ZH | Jun 27, 2024 | 2.59 | -8.48 |
Zhongchao A | ZCMD | Jun 27, 2024 | 1.28 | +4.68 |
Ziff Davis | ZD | Jun 27, 2024 | 54.60 | -0.11 |
Zillow Group A | ZG | Jun 27, 2024 | 45.38 | +0.38 |
Zillow Group C Capital Stock | Z | Jun 27, 2024 | 46.80 | +0.65 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.